Polly Murphy

Directeur/Bestuurslid bij CELCUITY INC.

Vermogen: 286 153 $ op 31-05-2024

59 jaar

Health Technology

Consumer Services

Profiel

Polly A.
Murphy is an Independent Director at Atea Pharmaceuticals, Inc., Celcuity, Inc., and Chief Business Officer at UroGen Pharma Ltd.
She previously worked as Vice President-Commercial Development at Pfizer Inc. from 2019 to 2020 and as Senior VP-Business & Scientific Services at The Scripps Research Institute from 2005 to 2008.
Murphy holds a doctorate from Iowa State University and an MBA from Nova Southeastern University, Inc.

Bekende belangen in openbare bedrijven

Onderneming	Datum	Aantal aandelen	Totale waarde	Waarderingsdatum
ATEA PHARMACEUTICALS, INC. 0.07%	16-06-2024	56 445 ( 0.07% )	207 153 $	31-05-2024
CELCUITY INC. 0.02%	04-06-2024	5 000 ( 0.02% )	79 000 $	31-05-2024

Actieve functies van Polly Murphy

Bedrijven	Functie	Begin
UROGEN PHARMA LTD.	Corporate Officer/Principal	09-09-2020
ATEA PHARMACEUTICALS, INC.	Directeur/Bestuurslid	01-08-2020
CELCUITY INC.	Directeur/Bestuurslid	12-09-2022

Alle actieve functies van Polly Murphy

Eerdere bekende functies van Polly Murphy

Bedrijven	Functie	Einde
PFIZER, INC.	Corporate Officer/Principal	01-08-2020
The Scripps Research Institute The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California.	Corporate Officer/Principal	01-08-2008